Lovastatin and thalidomide have a combined effect on the rate of multiple myeloma cell apoptosis in short term cell culturesDMOSZYNSKA, Anna; PODHORECKA, Monika; KLIMEK, Piotr et al.European journal of clinical pharmacology. 2006, Vol 62, Num 4, pp 325-329, issn 0031-6970, 5 p.Article

T type 1/type 2 subsets balance in B-cell chronic lymphocytic leukemia: the three-color flow cytometry analysisPODHORECKA, Monika; DMOSZYNSKA, Anna; ROLINSKI, Jacek et al.Leukemia research. 2002, Vol 26, Num 7, pp 657-660, issn 0145-2126Article

Stimulation of erythropoiesis by thalidomide in multiple myeloma patients : its influence on FasL, TRAIL and their receptors on erythroblastsGRZASKO, Norbert; DMOSZYNSKA, Anna; HUS, Marek et al.Haematologica (Roma). 2006, Vol 91, Num 3, pp 386-389, issn 0390-6078, 4 p.Article

Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia: Efficacy and toxicity in comparison with previous treatmentROBAK, Tadeusz; BONSKI, Jerzy Z; KASZNICKI, Marek et al.European journal of haematology. 2002, Vol 69, Num 1, pp 27-36, issn 0902-4441Article

Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia : report of a prospective, randomized, multicenter trialROBAK, Tadeusz; BLONSKI, Jerzy Z; CEGLAREK, Bernadeta et al.Blood. 2000, Vol 96, Num 8, pp 2723-2729, issn 0006-4971Article

Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemiaBOJARSKA-JUNAK, Agnieszka; ROLINSKI, Jacek; WASIK-SZCZEPANEKO, Ewa et al.Haematologica (Roma). 2002, Vol 87, Num 5, pp 490-499, issn 0390-6078Article

Intravascular B-cell lymphoma in a 38-year-old woman: a case reportWACH, Matgorzata; DMOSZYNSKA, Anna; SKOMRA, Danuta et al.Annals of hematology (Print). 2001, Vol 80, Num 4, pp 224-227, issn 0939-5555Article

A dose exploration, phase I/II study of administration of continuous erythropoietin receptor activator once every 3 weeks in anemic patients with multiple myeloma receiving chemotherapyDMOSZYNSKA, Anna; KLOCZKO, Janusz; ROKICKA, Malgorzata et al.Haematologica (Roma). 2007, Vol 92, Num 4, pp 493-501, issn 0390-6078, 9 p.Article

Effect of FCGR2A and FCGR3A variants on CLL outcomeDORNAN, David; SPLEISS, Olivia; WARZOCHA, Krzysztof et al.Blood. 2010, Vol 116, Num 20, pp 4212-4222, issn 0006-4971, 11 p.Article

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia : final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trialROBAK, Tadeusz; JAMROZIAK, Krzysztof; WOJTASZKO, Maria et al.Blood. 2007, Vol 109, Num 9, pp 3672-3675, issn 0006-4971, 4 p.Article

Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple MyelomaDIMOPOULOS, Meletios; SPENCER, Andrew; CORSO, Alessandro et al.The New England journal of medicine. 2007, Vol 357, Num 21, pp 2123-2132, issn 0028-4793, 10 p.Article

Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemiaGIANNOPOULOS, Krzysztof; SCHMITT, Michael; KOWAL, Malgorzata et al.Oncology reports. 2008, Vol 20, Num 3, pp 677-682, issn 1021-335X, 6 p.Article

Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma : Combination therapy improves time to progressionORLOWSKI, Robert Z; NAGLER, Arnon; SPICKA, Ivan et al.Journal of clinical oncology. 2007, Vol 25, Num 25, pp 3892-3901, issn 0732-183X, 10 p.Article

Alemtuzumab Compared With Chlorambucil As First-Line Therapy for Chronic Lymphocytic LeukemiaHILLMEN, Peter; SKOTNICKI, Aleksander B; ROBAK, Tadeusz et al.Journal of clinical oncology. 2007, Vol 25, Num 35, pp 5616-5623, issn 0732-183X, 8 p.Article

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropeniaWALSH, Thomas J; TEPPLER, Hedy; DEPAUW, Ben E et al.The New England journal of medicine. 2004, Vol 351, Num 14, pp 1391-1402, issn 0028-4793, 12 p.Article

Cladribine, But Not Fludarabine, Added to Daunorubicin and Cytarabine During Induction Prolongs Survival of Patients With Acute Myeloid Leukemia: A Multicenter, Randomized Phase III StudyHOLOWIECKI, Jerzy; GROSICKI, Sebastian; KLOCZKO, Janusz et al.Journal of clinical oncology. 2012, Vol 30, Num 20, pp 2441-2448, issn 0732-183X, 8 p.Article

Natural killer-like T CD3⁺/CD16⁺CD56⁺ cells in chronic lymphocytic leukemia: Intracellular cytokine expression and relationship with clinical outcomeBOJARSKA-JUNAK, Agnieszka; HUS, Iwona; SIEKLUCKA, Malgorzata et al.Oncology reports. 2010, Vol 24, Num 3, pp 803-810, issn 1021-335X, 8 p.Article

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple MyelomaSAN MIGUEL, Jesus F; SCHLAG, Rudolf; DMOSZYNSKA, Anna et al.The New England journal of medicine. 2008, Vol 359, Num 9, pp 906-917, issn 0028-4793, 12 p.Article

Immunotherapy with irradiated autologous leukemic cells in patients with B-CLL in early stagesHUS, Iwona; KAWIAK, Jerzy; TABARKIEWICZ, Jacek et al.Oncology reports. 2008, Vol 20, Num 2, pp 443-451, issn 1021-335X, 9 p.Article

Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blastsLI LI; GIANNOPOULOS, Krzysztof; SCHMITT, Michael et al.International journal of oncology. 2006, Vol 28, Num 4, pp 855-861, issn 1019-6439, 7 p.Article